One Hong Kong Pharma Digital Technology Holdings Insider Raised Their Stake In The Previous Year
AI Sentiment
Positive
7/10
as of 11-28-2025 11:04am EST
Hong Kong Pharma Digital Technology Holdings Ltd operates in two main categories: (i) OTC pharmaceutical cross-border e-commerce supply chain services, conducted through its Hong Kong subsidiary, Joint Cross Border, which it refers to as the Supply Chain Services division, and (ii) OTC pharmaceutical cross-border procurement and distribution, conducted through its Hong Kong subsidiary, V-Alliance, which it referred to as the Procurement and Distribution division. Based in Hong Kong, Joint Cross Border has established itself as a provider of third-party supply chain services in Mainland China's OTC pharmaceutical cross-border e-commerce market.
| Founded: | 2016 | Country: | Hong Kong |
| Employees: | N/A | City: | N/A |
| Market Cap: | 10.6M | IPO Year: | 2025 |
| Target Price: | N/A | AVG Volume (30 days): | 142.5K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.00 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.81 - $3.79 | Next Earning Date: | 08-14-2025 |
| Revenue: | $20,313,818 | Revenue Growth: | 21.72% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Machine learning model trained on 25+ technical indicators
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
HKPD Breaking Stock News: Dive into HKPD Ticker-Specific Updates for Smart Investing
AI Sentiment
Positive
7/10
See how HKPD stacks up against similar companies in the market
Enhance your trading experience with our free tools
The information presented on this page, "HKPD Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.